Reply
Published in The Journal of Infectious Diseases • May 1, 2002
NobleIDNI4P92W25R36S16
Authors:,,
Carlo Federico Perno
Alessandro Cozzi‐Lepri
Claudia Balotta
Abstract
To the Editor-Perno et al. [1] report that the number of pretherapy secondary mutations in human immunodeficiency virus (HIV) type 1 protease and the combination of mutations at codons 10 and 36 are associated with poorer outcome for patients commencing protease inhibitor (PI)-based combination anti...
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!